A Randomized, Placebo-Controlled Phase III Extension Trial of the Long-Term Safety and Tolerability of Anifrolumab in Active Systemic Lupus Erythematosus
一项随机、安慰剂对照的III期扩展试验,旨在评估Anifrolumab在活动性系统性红斑狼疮中的长期安全性和耐受性
期刊:Arthritis & Rheumatology
影响因子:10.9
doi:10.1002/art.42392
Kalunian, Kenneth C; Furie, Richard; Morand, Eric F; Bruce, Ian N; Manzi, Susan; Tanaka, Yoshiya; Winthrop, Kevin; Hupka, Ihor; Zhang, Lijin Jinny; Werther, Shanti; Abreu, Gabriel; Hultquist, Micki; Tummala, Raj; Lindholm, Catharina; Al-Mossawi, Hussein